Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04260802
Title A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Ocellaris Pharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
Ottawa Hospital Cancer Centre (OHRI) RECRUITING Ottawa Ontario Canada Details
Princess Margaret Hospital RECRUITING Toronto Ontario M5G 2C1 Canada Details
Jewish General Hospital - Clinical Research Unit RECRUITING Montreal Quebec H3T 1E2 Canada Details
Centre hospitalier de l'Université de Montréal (CHUM) RECRUITING Montréal Quebec H2X 0A9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field